SingMedical   

The Next Medical Stock to watch

If can broke 40

http://www.cakap.net/gann-square-of-9/?s=sing+medical& cp=0.39

 

Many retails taking profits at 390 they do not want more?

 

Not bad, I loaded a lot since $0.375, can wait for $0.4+ to offload!

easywin      ( Date: 29-Jul-2019 11:37) Posted: Buy while price still cheap! JesseTyler      ( Date: 29-Jul-2019 11:15) Posted: $0.395 now, may test $0.41 before lunchtime

 

Buy while price still cheap!

JesseTyler      ( Date: 29-Jul-2019 11:15) Posted: $0.395 now, may test $0.41 before lunchtime. JesseTyler      ( Date: 29-Jul-2019 11:11) Posted: Target price for SingMedical today: between $0.395 to $0.4

 

$0.395 now, may test $0.41 before lunchtime.

JesseTyler      ( Date: 29-Jul-2019 11:11) Posted: Target price for SingMedical today: between $0.395 to $0.43 JesseTyler      ( Date: 29-Jul-2019 11:05) Posted: I agree, the buying has been going non-stop recently

 

Target price for SingMedical today: between $0.395 to $0.43

JesseTyler      ( Date: 29-Jul-2019 11:05) Posted: I agree, the buying has been going non-stop recently. n3wbie      ( Date: 08-Jul-2019 12:06) Posted: yup, agree that it is relatively cheap, considering that they last issued rights at 48c. so they are trading ~18% below the rights price presently. good for LT but i guess the ST price performance is still subject to broad market sentimen

 

I agree, the buying has been going non-stop recently.

n3wbie      ( Date: 08-Jul-2019 12:06) Posted: yup, agree that it is relatively cheap, considering that they last issued rights at 48c. so they are trading ~18% below the rights price presently. good for LT but i guess the ST price performance is still subject to broad market sentiment sunview      ( Date: 08-Jul-2019 11:51) Posted: Agree, but even compared with the specialist players that you mentioned SMG is cheap in terms of historical PE and especially P/B

 

wowww ... very very strong buying ... 

n3wbie      ( Date: 08-Jul-2019 12:06) Posted: yup, agree that it is relatively cheap, considering that they last issued rights at 48c. so they are trading ~18% below the rights price presently. good for LT but i guess the ST price performance is still subject to broad market sentiment sunview      ( Date: 08-Jul-2019 11:51) Posted: Agree, but even compared with the specialist players that you mentioned SMG is cheap in terms of historical PE and especially P/B

 

yup, agree that it is relatively cheap, considering that they last issued rights at 48c. so they are trading ~18% below the rights price presently. good for LT but i guess the ST price performance is still subject to broad market sentiment

sunview      ( Date: 08-Jul-2019 11:51) Posted: Agree, but even compared with the specialist players that you mentioned SMG is cheap in terms of historical PE and especially P/B. n3wbie      ( Date: 08-Jul-2019 11:40) Posted: hard to compare them as they are not apple-to-apple comparison. HMI is asset-based hospital so valuations are naturally higher, along the likes of RMG. the multiples and valuation metrics for SMG should be benchmarked to the other asset-light specialist players such as TalkMed, ISEC, HC Surgical. just my two cents worth but I do agree that SMG at present price is cheap, even relative to peers and its own historical multiple

 

Agree, but even compared with the specialist players that you mentioned SMG is cheap in terms of historical PE and especially P/B.

n3wbie      ( Date: 08-Jul-2019 11:40) Posted: hard to compare them as they are not apple-to-apple comparison. HMI is asset-based hospital so valuations are naturally higher, along the likes of RMG. the multiples and valuation metrics for SMG should be benchmarked to the other asset-light specialist players such as TalkMed, ISEC, HC Surgical. just my two cents worth but I do agree that SMG at present price is cheap, even relative to peers and its own historical multiples sunview      ( Date: 08-Jul-2019 11:11) Posted: HMI is going to be privatised at $0.73, representing 27.1x historical PE and 5.6x Price/Book. SingMedical, about one-third of the size of HMI in terms of market cap, is trading at $0.39 or about 14x historical PE or 1.4x Price/Book. UOB-KH has a BUY recommendation for the stock and a target price of $0.62. (vested at $0.385)

 

hard to compare them as they are not apple-to-apple comparison.

HMI is asset-based hospital so valuations are naturally higher, along the likes of RMG. the multiples and valuation metrics for SMG should be benchmarked to the other asset-light specialist players such as TalkMed, ISEC, HC Surgical. just my two cents worth but I do agree that SMG at present price is cheap, even relative to peers and its own historical multiples

sunview      ( Date: 08-Jul-2019 11:11) Posted: HMI is going to be privatised at $0.73, representing 27.1x historical PE and 5.6x Price/Book. SingMedical, about one-third of the size of HMI in terms of market cap, is trading at $0.39 or about 14x historical PE or 1.4x Price/Book. UOB-KH has a BUY recommendation for the stock and a target price of $0.62. (vested at $0.385)

 

HMI is going to be privatised at $0.73, representing 27.1x historical PE and 5.6x Price/Book.

SingMedical, about one-third of the size of HMI in terms of market cap, is trading at $0.39 or about 14x historical PE or 1.4x Price/Book.
UOB-KH has a BUY recommendation for the stock and a target price of $0.62.

(vested at $0.385)

 

Vested, the price is definitely undervalued now.

Once the handover by existing shareholders to CHA is completed, it will back to normal.

Good to see change of management, those previous shareholders and directors only care about own interest instead of rewarding the public.

 

any thoughts about this stock? seems to be trading below peers' valuation at ~13x FY19 PE. i recalled that they did the rights issue at 48c so present price is some 20% discount from rights and 37% discount from the price CHA bought from the insiders

 

SMG has approved by EGM the
Proposed allotment and issuance of an aggregate of up to 23,640,662 new ordinary shares in the capital of the Company to CHA Healthcare Singapore Pte. Ltd., upon the conversion of a convertible loan of S$10 million

If the conversion is exercised by CHA, it would raise CHA's stake in SMG from 24.13% to 27.69%

CHA is an international subsidiary of Korean CHA Medical Group: a leading Korean comprehensive healthcare provider.
CHA also operates ?CHA Bio Group? which includes 2 companies listed on the Korea Exchange and primarily focused on cell therapy and pharmaceuticals with a combined market capitalisation of S$1,240.4 million as of 15 February 2017.

Looks like SMG is slowly transforming into a comprehensive regional healthcare provider given CHA's network and long established reputation.
A potential multi bagger in the making of one has a longer investment time frame.

SmallSmall      ( Date: 15-Apr-2019 09:22) Posted: The next Raffles Medical for longer term investment. Just look at its growth rates !

 

The next Raffles Medical for longer term investment. Just look at its growth rates !

 

Hi Folks, sharing some reviews out there on recent announcements by SingMed. Think maybe good to have the CHA Healthcare Group acquiring more stakes and commit themselves as strategic partner to SingMed. Maybe  2 more years general offer to all shareholders after transformation of SingMed into established medical group?
https://dividendpassiveincome.blogspot.com/2019/02/hidden-gem-with-explosive-growth_24.html

 

The grow of SingM by its own can be very limited, after the take over, news may come out.

The unhappy part was why not public offer?

 

Obviously management trying to cash out. These guys bought the company stocks (took over) when it was 0.1xx . Now reaping the benefits.

If key management personnel sees intrinsic value and growth in this company, why are they selling HALF their stakes? Super smelly management, avoid

idunnoleh      ( Date: 21-Feb-2019 11:12) Posted: I agree with you that retail/minority shareholders like me are losing out from a corp gov standpoint. if they want to acquire more shares, why not open it to everyone? Sadly, this stock is severely undervalued and illiquid. Even if its valued at 0.60+ cents, the market is not moving close to that.  But I believe in its intrinsic value and in the long term, so I will continue to hold until the market sees its potential or taking it private. Clearly the financials are proving that this stock is a hidden gem.   alexchew      ( Date: 21-Feb-2019 10:36) Posted: to me, obviously, mgt sold out minority.. they offloaded at 0.60+, and you guys are stuck at 0.4+... Why can' t a private placement of new shares be done to make this deal beneficial to all instead of the mgt only exercise? Company did not reap any benefits out of this deal.

 

SingM is currently undervalued due to right issue a year ago. The takeover price has suggested that the company shares did worth $0.605.

On one hand, hold to see the market price go to $0.60, another hand feeling sad on those selfish management.

I will try to schedule my timetable in order attend the EGM to meet those directors. How to say. Happy to see company in better growth position and upset on their escape.